Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment - a prospective study of 160 patients. Blood, 63, 468-476. BATAILLE, R-. JOURDAN, M., ZHANG, X.G. & KLEIN, B. (1989). Serum levels of interleukin 6, a potent myeloma cell growth factor, as a ...
The treatment of multiple myeloma with docetaxel (an ECOG study) Leuk Res. 2003; 27 (8):751–754. doi: 10.1016/S0145-2126(02)00344-2. [ Cross Ref ]Friedenberg WR, Graham D, Greipp P, Blood E, Winston RD (2003) The treatment of multiple myeloma with docetaxel (an ECOG study). ...
Treatment for Multiple Myeloma Lesson Summary Learning Outcomes Register to view this lesson Are you a student or a teacher? I am a student I am a teacher Bryce S. Student United States Create an Account A textbook can only get you so far. The video aid provided by Study.com really hel...
For most multiple myeloma patients who have been effectively treated, the M protein and other major index will be stable in a certain time, which is called the platform period. In this case, the patient can undergo immunotherapy and needs dynamic observation, etc. What are the Treatment ...
“The diagnosis, workup, and treatment of myeloma have dramatically changed over the past 10 years. The therapeutic goal is to obtain deep remissions that translate into improved progression-free and overall survival. With combination therapy using immunomodulatory drugs, proteasome inhibitors, monoclonal...
Treatment of multiple myeloma: an Argentine Group for the Treatment of Acute Leukemia Study. Sackmann-Muriel F, Maschio M, Santarelli MT, Pavlovsky S. K Dhingra - 《Journal of Clinical Oncology》 被引量: 0发表: 1988年 Results of therapy for Hodgkin's disease in childhood In Argentina, no ...
The purpose of the study was to ascertain whether the prognostic significance of staging in multiple myeloma (MM) is influenced by the aggressiveness of effective induction treatment and/or by continuing or discontinuing maintenance chemotherapy. Patients with untreated stage I MM (defined according to...
Home Multiple Myeloma - A New Era of Treatment Strategies Chapter 7 View Sample Chapter 7 Sonia Vallet and Noopur Raje Abstract More than 80% of multiple myeloma (MM) patients present with bone involvement frequently develop serious complications that negatively affect both quality of life and overa...
Interferon in the Treatment of Multiple Myeloma: Further study is required to determine which subsets of patients with myeloma will derive most benefit fro... Background The role of interferon (IFN) in the treatment of multiple myeloma has been investigated for nearly two decades. The mechanisms ...
marrow cells and some white blood cells release this hormone-like substance. When it's used as a drug, it can slow the growth of myeloma cells. You might take interferon if you've had treatment and are in remission, which means your doctor can't spot any signs of myeloma in your body...